Skip to main content
Equibles

Milos Miljkovic

Cartesian Therapeutics, Inc. (RNAC)

Equibles does not estimate personal net worth.

Get an email with a short summary when Cartesian Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get RNAC alerts

About Milos Miljkovic

Cartesian Therapeutics, Inc. reported in an 8-K filed November 13, 2023 that Milos Miljkovic was appointed Chief Medical Officer. The proxy statement of Cartesian Therapeutics, Inc. reports total compensation of $1,657,535 for Milos Miljkovic in fiscal 2025, including a base salary of $439,000. Disclosed compensation is on record for 2 fiscal years. Cartesian Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cartesian Therapeutics, Inc. includes Carsten Brunn (CEO and Board Member), Carsten Brunn, Ph.D. (Chairman), Blaine Davis (CFO and Chief Accounting Officer) and 7 others.

“The combined company will be led by Selecta's Chief Executive Officer, Carsten Brunn, Ph.D., and current Chief Financial Officer, Blaine Davis, as well as several members of the legacy Cartesian team, including Metin Kurtoglu, M.D., Ph.D., as Chief Operating Officer, Milos Miljkovic, M.D., as Chief Medical Officer, Chris Jewell, Ph.D., as Chief Scientific Officer, and Emily English, Ph.D., as Vice President of Quality.”
Cartesian Therapeutics, Inc. Form 8-K, filed November 13, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Cartesian Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cartesian Therapeutics, Inc. (RNAC) $439,000 $1,657,535
2024 Cartesian Therapeutics, Inc. (RNAC) $392,308 $1,349,018

Recent activity